Deceptive Inquiries Made to Drug Information Departments

Abstract

Acute concern is created among drug information department staff in pharmaceutical firms whenever calls are received from individuals who seem deceitful. This paper lists some of the identifying characteristics of these calls, discusses the hazards involved in responding to these callers, and differentiates these calls from those by health care professionals who received disinformation. Measures are suggested to minimize the impact of deceptive callers.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Bowen E. The House in Paris. Part I, Chap. 5. New York, NY: Alfred A. Knopf;1935:55.

    Google Scholar 

  2. 2.

    Radice B, advisory ed. Cicero: Selected Works. VI. Test Cases in Business. New York, NY: Penguin Books; 1971:177–181.

    Google Scholar 

  3. 3.

    Johnson S. The Idler, Number 80. 1758. In: Curwen HD, (ed. A Johnson Sampler. Cambridge, MA: Harvard University Press; 1963:120.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Charles F. Curran PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Curran, C.F. Deceptive Inquiries Made to Drug Information Departments. Ther Innov Regul Sci 36, 435–438 (2002). https://doi.org/10.1177/009286150203600223

Download citation

Key Words

  • Drug information
  • Drug inquiries
  • Deception